Core B Core B, the Biochemical and Metabolic Services Core, will assist the projects in processes where specialized equipment and experienced personnel can greatly increase the efficiency and accuracy of results beyond that which could be achieved by the individual projects. These processes include proteomic, biochemical and metabolic assays carried out in vitro and in vivo as well as the development of genetic constructs to alter expression of candidate genes. The services performed by the Biochemical and Metabolic Profiling Core can be broken down into six broad categories: 1) Analysis of plasma samples; 2) Analysis of tissue samples; 3) In vivo metabolic/physiologic tests 4) Expression modulation to validate candidate genes 5) Proteomic analysis and 6) Specialized biochemical and metabolic analysis designed to address specific project needs. The methods and assays employed have all been fully implemented and used successfully by our experienced personnel. This core strongly interacts with all the projects and with Core C (the Database, Computing and Statistics Core ) and has served as a vital component of the PPG for the past 20 years.

Public Health Relevance

Core B Core B assists the projects in processes where specialized equipment and experienced personnel can greatly increase the efficiency and accuracy of results beyond that which could be achieved by the individual projects. These processes include biochemical and metabolic assays carried out in vitro and in vivo as well as the development of genetic constructs to alter expression of candidate genes.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL028481-35
Application #
9689503
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Liu, Lijuan
Project Start
Project End
2021-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
35
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Small, Kerrin S; Todor?evi?, Marijana; Civelek, Mete et al. (2018) Regulatory variants at KLF14 influence type 2 diabetes risk via a female-specific effect on adipocyte size and body composition. Nat Genet 50:572-580
Mangul, Serghei; Yang, Harry Taegyun; Strauli, Nicolas et al. (2018) ROP: dumpster diving in RNA-sequencing to find the source of 1 trillion reads across diverse adult human tissues. Genome Biol 19:36
Cantor, Rita; Navarro, Linda; Pan, Calvin (2018) Identifying fenofibrate responsive CpG sites. BMC Proc 12:43
Rahmani, Elior; Schweiger, Regev; Shenhav, Liat et al. (2018) BayesCCE: a Bayesian framework for estimating cell-type composition from DNA methylation without the need for methylation reference. Genome Biol 19:141
Goldberg, Ira J; Reue, Karen; Abumrad, Nada A et al. (2018) Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop. Circulation 138:305-315
Hui, Simon T; Kurt, Zeyneb; Tuominen, Iina et al. (2018) The Genetic Architecture of Diet-Induced Hepatic Fibrosis in Mice. Hepatology 68:2182-2196
Kang, Eun Yong; Lee, Cue Hyunkyu; Furlotte, Nicholas A et al. (2018) An Association Mapping Framework To Account for Potential Sex Difference in Genetic Architectures. Genetics 209:685-698
Seldin, Marcus M; Koplev, Simon; Rajbhandari, Prashant et al. (2018) A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism. Cell Metab 27:1138-1155.e6
Lang, Jennifer M; Pan, Calvin; Cantor, Rita M et al. (2018) Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome. MBio 9:
Cherlin, Svetlana; Wang, Maggie Haitian; Bickeböller, Heike et al. (2018) Detecting responses to treatment with fenofibrate in pedigrees. BMC Genet 19:64

Showing the most recent 10 out of 518 publications